Basic Stats
| LEI | 549300CWYWPVCT8E9W67 |
| CIK | 1681622 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Varex Imaging Corporation
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 4, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATI |
|
| August 7, 2025 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2025 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2025 SALT LAKE CITY, August 7, 2025 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2025. 3QFY25 Summary •Revenues of $203 million •GAAP gross margin 33% | Non-GAAP gross margin* 34% •GAAP operating margin (40)% | Non-GAAP operating margin* 8% |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiza |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 1678 S. Pioneer Road, Salt Lake City, Utah 84104 ( |
|
| May 30, 2025 |
Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 This report for the year ended December 31, 2024 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). I.Overview a.Company Overview Varex Imaging Corporation (the “Company,” “our” or “us”) is a leading innovator, designer and manufacturer of X-ray imaging c |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organizatio |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 4, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| May 8, 2025 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2025 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2025 SALT LAKE CITY, May 8, 2025 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2025. 2QFY25 Summary •Revenues of $213 million •GAAP gross margin 36% | Non-GAAP gross margin* 36% •GAAP operating margin 10% | Non-GAAP operating margin* 12% • |
|
| April 24, 2025 |
Varex Imaging Corporation 1678 South Pioneer Road Salt Lake City, UT 84104 - USA www. |
|
| April 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2025 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-37860 81-343 |
|
| March 4, 2025 |
Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) VAREX IMAGING CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0. |
|
| March 4, 2025 |
As filed with the Securities and Exchange Commission on March 4, 2025 Registration No. |
|
| February 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2025 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-37860 81 |
|
| February 14, 2025 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF VAREX IMAGING CORPORATION The undersigned, Kimberley E. Honeysett, does hereby certify as follows: 1.The undersigned is the duly elected and acting Chief Legal Officer and Corporate Secretary of Varex Imaging Corporation, a Delaware corporation (the “Corporation”). 2.The Certificate of Incorporation of |
|
| February 6, 2025 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2025 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2025 SALT LAKE CITY, February 6, 2025 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary •Revenues of $200 million •GAAP gross margin 34% | Non-GAAP gross margin* 35% •GAAP operating margin 6% | Non-GAAP operating margin* 7% |
|
| February 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 3, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPOR |
|
| February 6, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| January 6, 2025 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No.1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organiz |
|
| January 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| December 30, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| December 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def |
|
| December 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-37860 81 |
|
| December 23, 2024 |
Execution Version FIRST SUPPLEMENTAL INDENTURE First Supplemental Indenture, dated as of December 20, 2024 (this “Supplemental Indenture”), among Varex Imaging Corporation, a Delaware corporation (the “Company”), the Guarantors listed on the signature pages hereto (collectively, the “Guarantors”), and Computershare Trust Company, N. |
|
| December 23, 2024 |
VAREX ANNOUNCES CLOSING OF PRIVATE OFFERING OF $125 MILLION OF SENIOR SECURED NOTES NEWS FOR IMMEDIATE RELEASE VAREX ANNOUNCES CLOSING OF PRIVATE OFFERING OF $125 MILLION OF SENIOR SECURED NOTES SALT LAKE CITY, December 23, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has closed its private offering (the “Offering”) of $125 million aggregate principal amount of 7. |
|
| December 17, 2024 |
VAREX ANNOUNCES PRICING OF PRIVATE OFFERING OF $125 MILLION OF SENIOR SECURED NOTES Exhibit 99.2 VAREX ANNOUNCES PRICING OF PRIVATE OFFERING OF $125 MILLION OF SENIOR SECURED NOTES SALT LAKE CITY, December 17, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $125 million aggregate principal amount of 7.875% senior secured notes due October 15, 2027 (the “notes”) at an offering price of 101.5% of the principal amo |
|
| December 17, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| December 17, 2024 |
AMENDMENT NO. 2 TO REVOLVING CREDIT AND GUARANTY AGREEMENT This AMENDMENT NO. 2 TO REVOLVING CREDIT AND GUARANTY AGREEMENT, dated as of December 13, 2024, but effective as of the Amendment No. 2 Effective Date (as defined herein) (this “Amendment”), is made and entered into by and among VAREX IMAGING CORPORATION, a Delaware corporation (the “Parent Borrower”), VAREX IMAGING WEST, LLC, a Delaware l |
|
| December 17, 2024 |
VAREX ANNOUNCES PRIVATE OFFERING OF $125 MILLION OF SENIOR SECURED NOTES Exhibit 99.1 VAREX ANNOUNCES PRIVATE OFFERING OF $125 MILLION OF SENIOR SECURED NOTES SALT LAKE CITY, December 16, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has commenced a private offering (the “Offering”), subject to market and other conditions, of $125 million aggregate principal amount of its 7.875% senior secured notes due October 15, 2027 (the “notes”). The notes off |
|
| December 17, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-37860 81 |
|
| November 19, 2024 |
List of Subsidiaries as of September 27, 2024 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation Direct Conversion Ltd United Kingdom Irradiation Systems, LLC Nevada, USA MeVis Medical Solutions AG (73.7%) Germany MeVis BreastCare GMBH (86.1%) Germany MeVis BreastCare GMBH & Co. KG (86.1%) Germany Oy Varex Imaging Finland Ltd. Finland Varex Imaging Americas Corporation Illinois, USA Varex Imaging Ar |
|
| November 19, 2024 |
Exhibit 4.1 DESCRIPTION OF VAREX’S CAPITAL STOCK The following is a summary of the material terms of Varex’s capital stock contained in Varex’s amended and restated certificate of incorporation and bylaws and the in the Delaware General Corporation Law (“DGCL”). The summaries and descriptions below do not purport to be complete statements of the relevant provisions of the certificate of incorporat |
|
| November 19, 2024 |
EXHIBIT 10.23 Execution Version AMENDMENT NO. 1 TO REVOLVING CREDIT AND GUARANTY AGREEMENT This AMENDMENT NO. 1 TO REVOLVING CREDIT AND GUARANTY AGREEMENT, dated as of August 30, 2024 (this “Amendment”), is made and entered into by and among VAREX IMAGING CORPORATION, a Delaware corporation (the “Parent Borrower”), VAREX IMAGING WEST, LLC, a Delaware limited liability company (together with the Pa |
|
| November 19, 2024 |
Varex Imaging Corporation Compensation Recovery Policy EXHIBIT 97.1 VAREX IMAGING CORPORATION COMPENSATION RECOVERY POLICY (Adopted and approved on November 17, 2023 and effective as of November 18, 2023) 1. Purpose Varex Imaging Corporation (collectively with its subsidiaries, the “Company”) has adopted this Compensation Recovery Policy (this “Policy”), which is designed to comply and will be interpreted in accordance with Section 10D of the Exchange |
|
| November 19, 2024 |
Varex Imaging Corporation Insider Trading Policy EXHIBIT 19.1 INSIDER TRADING POLICY A. POLICY Varex policy prohibits directors, officers1 and employees from trading on, or improperly disclosing or using, "inside" information. Inside information is information known to them through their relationship with or concerning Varex but not known to the investing public. This policy is intended to protect the reputation of Varex and its personnel and to |
|
| November 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 27, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION |
|
| November 19, 2024 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2024 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2024 SALT LAKE CITY, November 19, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2024. Q4 FY24 Summary •Revenues of $206 million •GAAP gross margin 33% | Non-GAAP gross margin* 33% •GAAP operating expense $56 million | Non-GAAP ope |
|
| November 19, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| October 9, 2024 |
VREX / Varex Imaging Corporation / Allspring Global Investments Holdings, LLC Passive Investment SC 13G/A 1 Varex20240930.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2) VAREX IMAGING CORP (Name of Issuer) COM (Title of Class of Securities) 92214X106 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| September 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or orga |
|
| August 1, 2024 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2024 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2024 SALT LAKE CITY, August 1, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2024. 3QFY24 Summary •Revenues $209 million •GAAP gross margin 32% | Non-GAAP gross margin* 32% •GAAP operating margin 4% | Non-GAAP operating margin* 7% •GAAP |
|
| August 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| August 1, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiza |
|
| May 28, 2024 |
Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023 This report for the year ended December 31, 2023 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). I.Overview a.Company Overview Varex Imaging Corporation (the “Company,” “our” or “us”) is a leading innovator, designer and manufacturer of X-ray imaging c |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 (State or other jurisdiction of incorporation or organization) (Commission File Number) 1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Address of principal executive offices) (Zip cod |
|
| May 2, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organizatio |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORA |
|
| May 2, 2024 |
EXHIBIT 10.2 EXECUTION VERSION DELAYED-DRAW TERM LOAN CREDIT AND GUARANTY AGREEMENT dated as of April 26, 2024 among VAREX IMAGING CORPORATION, as the Parent Borrower, CERTAIN SUBSIDIARIES OF PARENT BORROWER IDENTIFIED HEREIN, as Borrower and the Guarantors, as applicable, THE OTHER LOAN PARTIES FROM TIME TO TIME PARTY HERETO, and ZIONS CREDIT CORPORATION, as the Lender ACTIVE 696497506v9 TABLE OF |
|
| May 2, 2024 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2024 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2024 SALT LAKE CITY, May 2, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2024. 2QFY24 Summary •Revenues $206 million •GAAP gross margin 32% | Non-GAAP gross margin* 33% •GAAP operating margin 4% | Non-GAAP operating margin* 6% •GAAP |
|
| March 27, 2024 |
VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION Exhibit 99.1 VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION SALT LAKE CITY, March 27, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a senior secured revolving credit agreement (the “RLOC Facility”) for an initial aggregate principal amount of up to $155 million. Zions Bancorporation, N.A. (“Zions”) acted as lead arranger and bookrunner fo |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiza |
|
| March 27, 2024 |
Exhibit 10.1 Execution Version REVOLVING CREDIT AND GUARANTY AGREEMENT dated as of March 26, 2024 among VAREX IMAGING CORPORATION, as the Parent Borrower, CERTAIN SUBSIDIARIES OF PARENT BORROWER IDENTIFIED HEREIN, as the Borrowers and Guarantors, as applicable, THE OTHER LOAN PARTIES FROM TIME TO TIME PARTY HERETO, THE LENDERS FROM TIME TO TIME PARTY HERETO, THE ISSUING BANKS FROM TIME TO TIME PAR |
|
| February 16, 2024 |
Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Varex Imaging Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0. |
|
| February 16, 2024 |
As filed with the Securities and Exchange Commission on February 16, 2024 Registration No. |
|
| February 16, 2024 |
Varex Imaging Corporation 2020 Omnibus Stock Plan, as Amended and Restated Exhibit 99.1 VAREX IMAGING CORPORATION 2020 OMNIBUS STOCK PLAN, AS AMENDED AND RESTATED TABLE OF CONTENTS Page SECTION 1 BACKGROUND AND PURPOSE 1 1.1 Restatement Date 1 1.2 Purpose of the Plan 1 SECTION 2 DEFINITIONS 1 2.1 “1934 Act” 1 2.2 “Adoption Date” 1 2.3 “Affiliate” 1 2.4 “Award” 1 2.5 “Award Agreement” 1 2.6 “Board” 1 2.7 “Code” 1 2.8 “Committee” 1 2.9 “Company” 1 2.10 “Consultant” 2 2.11 |
|
| February 13, 2024 |
VREX / Varex Imaging Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Varex Imaging Corp Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ |
|
| February 13, 2024 |
VREX / Varex Imaging Corporation / COOKE & BIELER LP - NONE Passive Investment SC 13G 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Varex Imaging Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 92214X106 (CUSIP Number) Calendar Year 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 9, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| February 9, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Varex Imaging Corp (Name of Issuer) Common Stock (Title of Class of Securities) 92214X106 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi |
|
| February 9, 2024 |
Varex Imaging Corporation 2020 Omnibus Stock Plan, as Amended and Restated Exhibit 10.1 VAREX IMAGING CORPORATION 2020 OMNIBUS STOCK PLAN, AS AMENDED AND RESTATED TABLE OF CONTENTS Page SECTION 1 BACKGROUND AND PURPOSE 1 1.1 Restatement Date 1 1.2 Purpose of the Plan 1 SECTION 2 DEFINITIONS 1 2.1 “1934 Act” 1 2.2 “Adoption Date” 1 2.3 “Affiliate” 1 2.4 “Award” 1 2.5 “Award Agreement” 1 2.6 “Board” 1 2.7 “Code” 1 2.8 “Committee” 1 2.9 “Company” 1 2.10 “Consultant” 2 2.11 |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 29, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORP |
|
| February 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2024 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| February 6, 2024 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2024 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2024 SALT LAKE CITY, February 6, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024. 1QFY24 Summary •Revenues $190 million •GAAP gross margin 30% | Non-GAAP gross margin* 31% •GAAP operating margin 2% | Non-GAAP operating margin* 5% •GA |
|
| January 12, 2024 |
VREX / Varex Imaging Corporation / Allspring Global Investments Holdings, LLC Passive Investment SC 13G/A 1 Varex20231231.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1) VAREX IMAGING CORP (Name of Issuer) COM (Title of Class of Securities) 92214X106 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| December 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| December 27, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| November 16, 2023 |
Exhibit 4.1 DESCRIPTION OF VAREX’S CAPITAL STOCK The following is a summary of the material terms of Varex’s capital stock contained in Varex’s amended and restated certificate of incorporation and bylaws and the in the Delaware General Corporation Law (“DGCL”). The summaries and descriptions below do not purport to be complete statements of the relevant provisions of the certificate of incorporat |
|
| November 16, 2023 |
List of Subsidiaries as of September 29, 2023 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 3901 Carnation Street, LLC Illinois, USA Direct Conversion Ltd United Kingdom Irradiation Systems, LLC Nevada, USA MeVis Medical Solutions AG (73.7%) Germany Oy Varex Imaging Finland Ltd. Finland Varex Imaging Americas Corporation Illinois, USA Varex Imaging Arabia, LLC (75%) Saudi Arabia Varex Imagens B |
|
| November 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 29, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| November 14, 2023 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2023 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2023 SALT LAKE CITY, November 14, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2023. Q4 FY23 Summary •Revenues of $227 million •GAAP gross margin 34% | Non-GAAP gross margin* 36% •GAAP operating expense $54 million | Non-GAAP ope |
|
| August 1, 2023 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2023 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2023 SALT LAKE CITY, August 1, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2023. 3QFY23 Summary •Revenues $232 million •GAAP gross margin 33% | Non-GAAP gross margin* 34% •GAAP operating margin 10% | Non-GAAP operating margin* 13% •GA |
|
| August 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| August 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiza |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 (State or other jurisdiction of incorporation or organization) (Commission File Number) 1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Address of principal executive offices) (Zip cod |
|
| May 30, 2023 |
ls Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2022 This report for the year ended December 31, 2022 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). I.Overview a.Company Overview Varex Imaging Corporation (the “Company,” “our” or “us”) is a leading innovator, designer and manufacturer of X-ray component |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORA |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organizatio |
|
| May 2, 2023 |
VAREX ANNOUNCES STRONG FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2023 Exhibit 99.1 VAREX ANNOUNCES STRONG FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2023 SALT LAKE CITY, May 2, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2023. 2QFY23 Summary •Revenues $228 million •GAAP gross margin 32% | Non-GAAP gross margin* 33% •GAAP operating margin 7% | Non-GAAP operating margin* 10 |
|
| February 13, 2023 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-37860 81-3434516 (Commiss |
|
| February 9, 2023 |
VREX / Varex Imaging Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv02162-vareximagingcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Varex Imaging Corp. Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designa |
|
| January 31, 2023 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2023 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2023 SALT LAKE CITY, January 31, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2023. 1QFY23 Summary •Revenues $206 million •GAAP gross margin 31% | Non-GAAP gross margin* 32% •GAAP operating expense $50 million | Non-GAAP operating expe |
|
| January 31, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| January 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORP |
|
| January 12, 2023 |
VREX / Varex Imaging Corp / Allspring Global Investments Holdings, LLC Passive Investment SC 13G 1 Varex12312022.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) VAREX IMAGING CORP (Name of Issuer) COM (Title of Class of Securities) 92214X106 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2023 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| January 10, 2023 |
Exhibit 10.1 TRANSITION AND RELEASE AGREEMENT This Transition and Release Agreement (“Agreement”) is made and entered into between Brian Giambattista (“Employee”) and Varex Imaging Corporation (“Varex” or the “Company”) (collectively the “Parties,” and one of the Parties a “Party”) on January 10, 2023 (the “Effective Date”). RECITALS 1.WHEREAS, Employee is employed by Varex as Senior Vice Presiden |
|
| December 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| December 28, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ???) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Ru |
|
| November 18, 2022 |
List of Subsidiaries as of November 14, 2022 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 3901 Carnation Street, LLC Illinois, USA Direct Conversion AB Sweden Direct Conversion GmbH Germany Direct Conversion Ltd United Kingdom Irradiation Systems, LLC Nevada, USA MeVis Medical Solutions AG (73.7%) Germany Oy Direct Conversion Ltd. Finland Varex Imaging Americas Corporation Illinois, USA Varex |
|
| November 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION (Exact |
|
| November 18, 2022 |
Exhibit 4.1 DESCRIPTION OF VAREX?S CAPITAL STOCK The following is a summary of the material terms of Varex?s capital stock contained in Varex?s amended and restated certificate of incorporation and bylaws and the in the Delaware General Corporation Law (?DGCL?). The summaries and descriptions below do not purport to be complete statements of the relevant provisions of the certificate of incorporat |
|
| November 18, 2022 |
Exhibit 10.11 CHANGE IN CONTROL AGREEMENT FOR [INSERT TITLE] CHANGE IN CONTROL AGREEMENT THIS CHANGE IN CONTROL AGREEMENT (?Agreement?) is entered into as of [Date] (the ?Effective Date?), by and between Varex Imaging Corporation, a Delaware corporation (the ?Company?)1, and [Employee], an employee of the Company or one of its subsidiaries (?Employee?). [This Agreement replaces and supersedes any |
|
| November 15, 2022 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2022 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2022 SALT LAKE CITY, November 15, 2022 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2022. Q4 FY22 Summary ?Record revenues of $231 million ?GAAP gross margin 32% | Non-GAAP gross margin* 33% ?GAAP operating expense $50 million | Non-G |
|
| November 15, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2022 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| August 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No.1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2022 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of (Commis |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATI |
|
| August 2, 2022 |
VAREX NAMES KATHLEEN L. BARDWELL TO BOARD OF DIRECTORS Exhibit 99.2 VAREX NAMES KATHLEEN L. BARDWELL TO BOARD OF DIRECTORS SALT LAKE CITY, August 2, 2022 – Varex Imaging Corporation (“Varex”) (Nasdaq: VREX) today announced that Kathleen L. Bardwell has been appointed to the company’s Board of Directors, effective July 29, 2022. Ms. Bardwell is the former Senior Vice President, Regulatory Affairs & Compliance for STERIS Corporation, a leading provider |
|
| August 2, 2022 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2022 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2022 SALT LAKE CITY, July 29, 2022 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2022. 3QFY22 Summary • Revenues $214 million • GAAP gross margin 34% | Non-GAAP gross margin* 35% • GAAP operating expense $50 million | Non-GAAP operating expe |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2022 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organizat |
|
| May 31, 2022 |
Conflict Minerals Report as required by Items 1.01 and 1.02. Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2021 This report for the year ended December 31, 2021 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?). I.Overview a.Company Overview Varex Imaging Corporation (the ?Company,? ?our? or ?us?) is a leading innovator, designer and manufacturer of X-ray tubes, di |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Add |
|
| May 4, 2022 |
Exhibit 10.1 LIBOR TRANSITION AMENDMENT THIS LIBOR TRANSITION AMENDMENT (this ?Agreement?), dated as of March 9, 2022 (the ?Amendment Effective Date?), is entered into among Varex Imaging Corporation, a Delaware corporation (the ?Parent Borrower?), Varex Imaging West, LLC, a Delaware limited liability company (together with the Parent Borrower, collectively, the ?U.S. Borrowers? and each, individu |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| May 3, 2022 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2022 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2022 SALT LAKE CITY, May 3, 2022 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2022. 2QFY22 Summary ? Revenues $215 million ? GAAP gross margin 33% | Non-GAAP gross margin* 34% ? GAAP operating expense $44 million | Non-GAAP operating expe |
|
| May 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organizatio |
|
| February 16, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2022 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organ |
|
| February 11, 2022 |
EX-FILING FEES 2 exhibit107-filingfeetable.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Varex Imaging Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee |
|
| February 11, 2022 |
As filed with the Securities and Exchange Commission on February 11, 2022 Registration No. |
|
| February 10, 2022 |
VREX / Varex Imaging Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Varex Imaging Corp. Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ |
|
| February 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2022 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| February 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORP |
|
| February 8, 2022 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2022 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2022 SALT LAKE CITY, February 8, 2022 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2022. 1QFY22 Summary ? Revenues $199 million ? GAAP gross margin 33% | Non-GAAP gross margin* 34% ? GAAP operating expense $51 million | Non-GAAP operating e |
|
| January 27, 2022 |
VREX / Varex Imaging Corp / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) VAREX IMAGING CORP (Name of Issuer) Common (Title of Class of Securities) 92214X106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| December 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| December 28, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ???) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Ru |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended October 1, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION (Exact na |
|
| November 19, 2021 |
List of Subsidiaries as of November 8, 2021 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 3901 Carnation Street, LLC Illinois, USA Dexela Limited United Kingdom Direct Conversion AB Sweden Direct Conversion GmbH Germany Direct Conversion Ltd United Kingdom MeVis Medical Solutions AG (73.7%) Germany Oy Direct Conversion Ltd. Finland Varex Imaging Americas Corporation Illinois, USA Varex Imagin |
|
| November 19, 2021 |
Form of Change in Control Agreement Exhibit 10.11 CHANGE IN CONTROL AGREEMENT FOR [INSERT TITLE] CHANGE IN CONTROL AGREEMENT THIS CHANGE IN CONTROL AGREEMENT (?Agreement?) is entered into as of [Date] (the ?Effective Date?), by and between Varex Imaging Corporation, a Delaware corporation (the ?Company?)1, and [Employee], an employee of the Company or one of its subsidiaries (?Employee?). [This Agreement replaces and supersedes any |
|
| November 19, 2021 |
Exhibit 4.1 DESCRIPTION OF VAREX?S CAPITAL STOCK The following is a summary of the material terms of Varex?s capital stock contained in Varex?s amended and restated certificate of incorporation and bylaws and the in the Delaware General Corporation Law (?DGCL?). The summaries and descriptions below do not purport to be complete statements of the relevant provisions of the certificate of incorporat |
|
| November 16, 2021 |
VAREX ANNOUNCES RECORD FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2021 Exhibit 99.1 VAREX ANNOUNCES RECORD FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2021 SALT LAKE CITY, November 16, 2021 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2021. 4QFY21 Summary ?Revenues $226 million ?GAAP gross margin 33% | Non-GAAP gross margin* 34% ?GAAP operating expense $49 million | Non-GAAP |
|
| November 16, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATI |
|
| August 3, 2021 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2021 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2021 SALT LAKE CITY, August 3, 2021 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2021. 3QFY21 Summary ? Revenues $211 million ? GAAP gross margin 35% | Non-GAAP gross margin* 36% ? GAAP operating expense $48 million | Non-GAAP operating exp |
|
| August 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2021 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiza |
|
| May 28, 2021 |
Conflict Minerals Report as required by Items 1.01 and 1.02. EX-1.01 2 exhibit1012020sd.htm EX-1.01 Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2020 This report for the year ended December 31, 2020 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). I.Overview a.Company Overview Varex Imaging Corporation (the “Company,” “our” or “us”) is a leading innovator, desig |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Add |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 2, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| May 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2021 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiza |
|
| May 4, 2021 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2021 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2021 SALT LAKE CITY, May 4, 2021 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2021. 2QFY21 Summary ? Revenues $204 million ? GAAP gross margin 32% | Non-GAAP gross margin* 35% ? GAAP operating expense $49 million | Non-GAAP operating expe |
|
| April 1, 2021 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2021 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation) (Commissio |
|
| April 1, 2021 |
Exhibit 16.1 March 31, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Varex Imaging Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Varex Imaging Corporation dated March 31, 2021. We agree with the statements concerning |
|
| February 17, 2021 |
Amended and Restated Bylaws of Varex Imaging Corporation, dated February 11, 2021 AMENDED AND RESTATED BYLAWS OF VAREX IMAGING CORPORATION Incorporated under the Laws of the State of Delaware (Effective as of February 11, 2021) These Amended and Restated Bylaws (as may be amended and/or restated from time to time, these ?Bylaws?) of Varex Imaging Corporation, a Delaware corporation (the ?Corporation?), are subject to and governed by the General Corporation Law of the State of Delaware (?DGCL?) and the Amended and Restated Certificate of Incorporation of the Corporation (as may be amended and/or restated from time to time, the ?Certificate of Incorporation?). |
|
| February 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2021 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organ |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) VAREX IMAGING CORP (Name of Issuer) COM (Title of Class of Securities) 92214X106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Varex Imaging Corp. Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ |
|
| February 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 1, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPOR |
|
| February 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2021 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organi |
|
| February 4, 2021 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2021 EX-99 2 exhibit991-q121earningsrel.htm EX-99 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2021 SALT LAKE CITY, February 4, 2021 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2021. 1QFY21 Summary •Revenues $177 million •GAAP gross margin 32% | Non-GAAP gross margin* 34% •GAAP operating |
|
| January 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use |
|
| December 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| December 30, 2020 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended October 2, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION (Exact na |
|
| November 30, 2020 |
Exhibit 10.18 EXECUTION VERSION U.S. $100,000,000 REVOLVING CREDIT AGREEMENT Dated as of September 30, 2020 among VAREX IMAGING CORPORATION, as Parent Borrower, THE SUBSIDIARIES OF THE PARENT BORROWER NAMED HEREIN, as Subsidiary Borrowers, THE BANKS AND FINANCIAL INSTITUTIONS NAMED HEREIN, as Lenders, BANK OF AMERICA, N.A., as an Issuing Bank, BANK OF AMERICA, N.A. and WELLS FARGO BANK, NATIONAL A |
|
| November 30, 2020 |
List of Subsidiaries as of November 3, 2020 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 3901 Carnation Street, LLC Illinois, USA Claymount Switzerland AG Switzerland Dexela Limited United Kingdom Direct Conversion AB (publ) (~98%) Sweden Direct Conversion GmbH Germany Direct Conversion Ltd United Kingdom MeVis Medical Solutions AG (73.7%) Germany Oy Direct Conversion Ltd. Finland Varex Imag |
|
| November 30, 2020 |
Letter dated June 8, 2020 by Varex Imaging Corporation to Shubham Maheshwari Exhibit 10.25 June 10, 2020 Shubham Maheshwari [address omitted] Dear Sam, We are pleased to confirm our offer of employment with Varex Imaging Corporation for the position of Chief Financial Officer reporting to Sunny Sanyal, Chief Executive Officer, with an estimated start date of July 20, 2020. Your work location will be Salt Lake City, UT and will require relocation to the area by July 20, 202 |
|
| November 30, 2020 |
Exhibit 4.3 Execution Version SENIOR SECURED NOTES INDENTURE Dated as of September 30, 2020 Among VAREX IMAGING CORPORATION THE GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee and Collateral Agent 7.875% SENIOR SECURED NOTES DUE 2027 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section |
|
| November 30, 2020 |
Exhibit 4.1 DESCRIPTION OF VAREX’S CAPITAL STOCK The following is a summary of the material terms of Varex’s capital stock contained in Varex’s amended and restated certificate of incorporation and bylaws and the in the Delaware General Corporation Law (“DGCL”). The summaries and descriptions below do not purport to be complete statements of the relevant provisions of the certificate of incorporat |
|
| November 17, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| November 17, 2020 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2020 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2020 SALT LAKE CITY, November 17, 2020 ? Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2020. 4QFY20 Summary ?Revenues were $170 million ?GAAP gross margin was 27% | non-GAAP gross margin* was 28% ?GAAP operating expense was $58 million |
|
| November 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commiss |
|
| October 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commi |
|
| October 1, 2020 |
VAREX ANNOUNCES CLOSING OF PRIVATE OFFERING OF $300 MILLION OF SENIOR SECURED NOTES Exhibit 99.1 NEWS FOR IMMEDIATE RELEASE VAREX ANNOUNCES CLOSING OF PRIVATE OFFERING OF $300 MILLION OF SENIOR SECURED NOTES SALT LAKE CITY, October 1, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has closed its private offering (the “Offering”) of $300 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 100% of the |
|
| September 28, 2020 |
VAREX ANNOUNCES PRICING OF PRIVATE OFFERING OF $300 MILLION OF SENIOR SECURED NOTES Exhibit 99.2 NEWS NOT FOR IMMEDIATE RELEASE VAREX ANNOUNCES PRICING OF PRIVATE OFFERING OF $300 MILLION OF SENIOR SECURED NOTES SALT LAKE CITY, September 28, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $300 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 100% of |
|
| September 28, 2020 |
VAREX ANNOUNCES PRIVATE OFFERING OF $300 MILLION OF SENIOR SECURED NOTES EX-99.1 2 tm2030909d2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NEWS NOT FOR IMMEDIATE RELEASE VAREX ANNOUNCES PRIVATE OFFERING OF $300 MILLION OF SENIOR SECURED NOTES SALT LAKE CITY, September 22, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has commenced a private offering (the “Offering”), subject to market and other conditions, of $300 million aggregate principal amount of seni |
|
| September 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commi |
|
| September 22, 2020 |
PART IV Exhibit 99.1 VAREX IMAGING CORPORATION EXHIBIT 99.1 TO FORM 8-K FOR THE YEAR ENDED DECEMBER 31, 2019 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm F-1 Consolidated Statements of Earnings for the fiscal years ended 2019, 2018 and 2017 F-5 Consolidated Statements of Comprehensive Earnings for the fiscal years ended 2019, 2018 and 2017 F-6 |
|
| September 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-37860 8 |
|
| September 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| September 3, 2020 |
VAREX NAMES TIMOTHY E. GUERTIN TO BOARD OF DIRECTORS Exhibit 99.1 VAREX NAMES TIMOTHY E. GUERTIN TO BOARD OF DIRECTORS SALT LAKE CITY, September 3, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced that Timothy E. Guertin, has been appointed to the company’s Board of Directors, effective September 2, 2020. Mr. Guertin is a member of the Board of Directors at Teradyne Inc., a maker of automated test equipment and industrial robotics, an |
|
| August 21, 2020 |
Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commissi |
|
| August 21, 2020 |
Form of 2020 Omnibus Stock Plan Restricted Stock Unit Award Agreement EX-10.2 3 tm2029151d1ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 VAREX IMAGING CORPORATION 2020 Omnibus Stock Plan RESTRICTED STOCK UNIT AGREEMENT Varex Imaging Corporation (the “Company”) hereby awards to the designated employee (the “Employee”), Restricted Stock Units under the Company’s 2020 Omnibus Stock Plan (the “Plan”). The Restricted Stock Units awarded under this Restricted Stock Unit Agreement |
|
| August 21, 2020 |
Form of 2020 Omnibus Stock Plan Nonqualified Stock Option Agreement Exhibit 10.1 VAREX IMAGING CORPORATION 2020 OMNIBUS STOCK PLAN NONQUALIFIED STOCK OPTION AGREEMENT Varex Imaging Corporation (the “Company”) hereby grants the employee (the “Employee”) named on the Summary of Grant Award (the “Grant Summary”) on the Grant Date*, a nonqualified stock option under the Company’s 2020 Omnibus Stock Plan (the “Plan”) to purchase shares of common stock of the Company (“ |
|
| August 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATI |
|
| August 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ◻Form 10-K ◻ Form 20-F ◻ Form 11-K ⌧ Form 10-Q ◻ Form 10-D ◻ Form N-SAR ◻ Form N-CSR For Period Ended: July 3, 2020 ◻ Transition Report on Form 10-K ◻ Transition Report on Form 20-F ◻ Transition Report on Form 11-K ◻ Transition Report on Form 10-Q ◻ Transition Report on Form |
|
| August 12, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organiz |
|
| August 12, 2020 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF FISCAL YEAR 2020 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF FISCAL YEAR 2020 SALT LAKE CITY, August 12, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2020. 3QFY20 Summary •Revenues were $171 million •GAAP gross margin was 15% | non-GAAP gross margin* was 26% •GAAP operating earnings margin was (15.7)% | |
|
| July 30, 2020 |
Costs Associated with Exit or Disposal Activities - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commission |
|
| July 28, 2020 |
SHUBHAM MAHESHWARI JOINS VAREX AS CHIEF FINANCIAL OFFICER Exhibit 99.1 SHUBHAM MAHESHWARI JOINS VAREX AS CHIEF FINANCIAL OFFICER SALT LAKE CITY, July 28, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced that effective July 27, 2020, Shubham “Sam” Maheshwari has joined Varex as its Chief Financial Officer (CFO), where he will lead the company’s finance and information technology organizations. “We are excited to have Sam join the Varex team |
|
| July 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commission |
|
| June 9, 2020 |
EX-10.2 4 tm2021182d5ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 [Dealer address] To: Varex Imaging Corporation 1678 S. Pioneer Road Salt Lake City, Utah 84104 Attention: Matthew Lowell, Treasurer Telephone No.: (650) 460-8190 Email: [email protected] From: [Dealer name] Re: Base Warrants Date: June 4, 2020 Dear Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation” |
|
| June 9, 2020 |
Exhibit 99.1 NEWS NOT FOR IMMEDIATE RELEASE VAREX ANNOUNCES CLOSING OF OFFERING OF $200 MILLION OF 4.00% CONVERTIBLE SENIOR NOTES DUE 2025, INCLUDING FULL EXERCISE OF OPTION TO PURCHASE ADDITIONAL NOTES SALT LAKE CITY, June 9, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced the closing of its previously announced offering of $200.0 million aggregate principal amount of its 4.00% Co |
|
| June 9, 2020 |
Exhibit 4.1 Execution Version VAREX IMAGING CORPORATION and WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of June 9, 2020 4.00% Convertible Senior Notes due 2025 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions. 1 Section 1.02. Other Definitions. 12 Section 1.03. Rules of Construction. 13 Article 2. The Notes 13 Section 2.01. F |
|
| June 9, 2020 |
Exhibit 10.1 [Dealer address] To: Varex Imaging Corporation 1678 S. Pioneer Road Salt Lake City, Utah 84104 Attention: Matthew Lowell, Treasurer Telephone No.: (650) 460-8190 Email: [email protected] From: [Dealer] Re: Base Call Option Transaction Date: June 4, 2020 Dear Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and condi |
|
| June 9, 2020 |
Exhibit 10.3 f [Dealer address] To: Varex Imaging Corporation 1678 S. Pioneer Road Salt Lake City, Utah 84104 Attention: Matthew Lowell, Treasurer Telephone No.: (650) 460-8190 Email: [email protected] From: [Dealer] Re: Additional Call Option Transaction Date: June 5, 2020 Dear Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms a |
|
| June 9, 2020 |
Exhibit 10.4 [Dealer address] To: Varex Imaging Corporation 1678 S. Pioneer Road Salt Lake City, Utah 84104 Attention: Matthew Lowell, Treasurer Telephone No.: (650) 460-8190 Email: [email protected] From: [Dealer name] Re: Additional Warrants Date: June 5, 2020 Dear Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and condition |
|
| June 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 4, 2020 (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emplo |
|
| June 5, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 5, 2020 (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emplo |
|
| June 5, 2020 |
VAREX PRICES OFFERING OF $175 MILLION 4.00% CONVERTIBLE SENIOR NOTES DUE 2025 Exhibit 99.1 VAREX PRICES OFFERING OF $175 MILLION 4.00% CONVERTIBLE SENIOR NOTES DUE 2025 SALT LAKE CITY, June 5, 2020 – Varex Imaging, Corp. (Nasdaq: VREX) today announced the pricing of its offering of $175.0 million aggregate principal amount of its 4.00% Convertible Senior Notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Secu |
|
| June 4, 2020 |
EX-10.1 2 tm2021182d210-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version AMENDMENT NO. 6 TO CREDIT AGREEMENT THIS AMENDMENT NO. 6 TO CREDIT AGREEMENT (this “Amendment”), dated as of June 3, 2020, is made between Varex Imaging Corporation (the “Borrower”), certain of the Borrower’s subsidiaries listed on the signature pages hereof under the heading “GUARANTORS” (each a “Guarantor”, and, collective |
|
| June 4, 2020 |
VAREX ANNOUNCES PROPOSED OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2025 Exhibit 99.1 VAREX ANNOUNCES PROPOSED OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2025 SALT LAKE CITY, June 4, 2020 – Varex Imaging, Corp. (Nasdaq: VREX) today announced that it intends to offer $150 million aggregate principal amount of its Convertible Senior Notes due 2025 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securiti |
|
| June 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 3, 2020 VAREX IMAGING CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 001-37860 81-3434516 (State or Other Jurisdiction of Incorporation) (Commission |
|
| June 4, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 4, 2020 (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emplo |
|
| June 2, 2020 |
SD 1 tm2021613-1sd.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1678 S. Pioneer Road, Salt |
|
| June 2, 2020 |
Conflict Minerals Report as required by Items 1.01 and 1.02. Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2019 This report for the year ended December 31, 2019 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). I. Overview a. Company Overview Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components including X-ray tub |
|
| May 13, 2020 |
TRANSITION AGREEMENT This Transition Agreement (“Agreement”) is made and entered into between Clarence Verhoef (“Mr. |
|
| May 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| May 12, 2020 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2020 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2020 SALT LAKE CITY, May 12, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2020. Varex also announced the withdrawal of its previously issued guidance for fiscal year 2020 due to the significant uncertainty surrounding the COVID-19 |
|
| May 12, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organizati |
|
| April 29, 2020 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 8 |
|
| April 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commissio |
|
| March 30, 2020 |
Exhibit 10.1 AMENDMENT NO. 5 TO CREDIT AGREEMENT THIS AMENDMENT NO. 5 TO CREDIT AGREEMENT (this “Amendment”), dated as of March 26, 2020, is made between Varex Imaging Corporation (the “Borrower”), certain of the Borrower’s subsidiaries listed on the signature pages hereof under the heading “GUARANTORS” (each a “Guarantor”, and, collectively, the “Guarantors”), the Lenders listed on the signature |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commissio |
|
| February 18, 2020 |
Varex Imaging Corporation 2020 Omnibus Stock Plan and related forms of award agreements Exhibit 99.1 VAREX IMAGING CORPORATION 2020 OMNIBUS STOCK PLAN Table of Contents Page SECTION 1 BACKGROUND AND PURPOSE 1 1.1 Effective Date 1 1.2 Purpose of the Plan 1 SECTION 2 DEFINITIONS 1 2.1 ?1934 Act? 1 2.2 ?Adoption Date? 1 2.3 ?Affiliate? 1 2.4 ?Award? 1 2.5 ?Award Agreement? 1 2.6 ?Board? 1 2.7 ?Code? 1 2.8 ?Committee? 1 2.9 ?Company? 2 2.10 ?Consultant? 2 2.11 ?Director? 2 2.12 ?Disabili |
|
| February 18, 2020 |
VREX / Varex Imaging Corp S-8 POS - - S-8 POS As filed with the Securities and Exchange Commission on February 18, 2020 Registration No. |
|
| February 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 3, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPOR |
|
| February 18, 2020 |
As filed with the Securities and Exchange Commission on February 18, 2020 As filed with the Securities and Exchange Commission on February 18, 2020 Registration No. |
|
| February 18, 2020 |
Varex Imaging Corporation 2020 Omnibus Stock Plan and related forms of award agreements EX-99.2 4 tm207941d2ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 VAREX IMAGING CORPORATION 2020 OMNIBUS STOCK PLAN Table of Contents Page SECTION 1 BACKGROUND AND PURPOSE 1 1.1 Effective Date 1 1.2 Purpose of the Plan 1 SECTION 2 DEFINITIONS 1 2.1 “1934 Act” 1 2.2 “Adoption Date” 1 2.3 “Affiliate” 1 2.4 “Award” 1 2.5 “Award Agreement” 1 2.6 “Board” 1 2.7 “Code” 1 2.8 “Committee” 1 2.9 “Company” 2 2.10 “Co |
|
| February 14, 2020 |
Exhibit 10.1 VAREX IMAGING CORPORATION 2020 OMNIBUS STOCK PLAN TABLE OF CONTENTS Page SECTION 1 BACKGROUND AND PURPOSE 1 1.1 Effective Date 1 1.2 Purpose of the Plan 1 SECTION 2 DEFINITIONS 1 2.1 “1934 Act” 1 2.2 “Adoption Date” 1 2.3 “Affiliate” 1 2.4 “Award” 1 2.5 “Award Agreement” 1 2.6 “Board” 1 2.7 “Code” 1 2.8 “Committee” 1 2.9 “Company” 2 2.10 “Consultant” 2 2.11 “Director” 2 2.12 “Disabili |
|
| February 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| February 12, 2020 |
VREX / Varex Imaging Corp NT 10-Q - - NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: January 3, 2020 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on |
|
| February 12, 2020 |
VREX / Varex Imaging Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Varex Imaging Corp Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ |
|
| February 11, 2020 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2020 EX-99.1 2 tm207429d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2020 SALT LAKE CITY, February 11, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2020. 1QFY20 Highlights · Revenues were $200 million · Gross margin was 31% | Adjusted gross margin* was 33% |
|
| February 11, 2020 |
CLARENCE VERHOEF ANNOUNCES PLAN TO RETIRE AS CFO OF VAREX IMAGING CORPORATION Exhibit 99.2 CLARENCE VERHOEF ANNOUNCES PLAN TO RETIRE AS CFO OF VAREX IMAGING CORPORATION SALT LAKE CITY, February 11, 2020 – Varex Imaging Corporation (Nasdaq: VREX) today announced that Clarence Verhoef has informed the company of his intention to retire as senior vice president and chief financial officer. Verhoef, 64, will remain in his current role until a successor is named, which Varex exp |
|
| February 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2020 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| January 2, 2020 |
VREX / Varex Imaging Corp DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| January 2, 2020 |
VREX / Varex Imaging Corp DEF 14A - - DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 23, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| December 23, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASE VAREX RECEIVES NOTIFICATION OF COMPLIANCE DELINQUENCY FROM NASDAQ – FILES FORM 10-K FOR FY2019 – REGAINS NASDAQ COMPLIANCE SALT LAKE CITY, DECEMBER 23, 2019 – Varex Imaging Corporation (Nasdaq: VREX) today announced the following: · On December 18, 2019, Varex received a notice from Nasdaq that, as a result of not having filed its Annual Report on Form 10-K for t |
|
| December 20, 2019 |
List of Subsidiaries as of November 5, 2019 EX-21.1 4 exhibit211-10xk2019.htm EXHIBIT 21.1 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation Varex Imaging Equipment (China) Co., Ltd. China MeVis Medical Solutions AG (73.7%) Germany Varex Imagens Brasil, Ltda. Brazil Varex Imaging Holdings, Inc. Delaware, USA Varex Imaging France SARL France Varex Imaging Deutschland AG Germany Varex Imaging Itali |
|
| December 20, 2019 |
EX-10.18 3 exhibit1018-10xk2019.htm EXHIBIT 10.18 Exhibit 10.18 VAREX IMAGING CORPORATION Grant Agreement - Deferred Stock Units (For grants made after May 25, 2018) GRANT AGREEMENT made effective as of , 20 (the “Grant Date”) between Varex Imaging Corporation, a Delaware corporation (the “Company”), and (the “Director”). 1.Grant of Deferred Stock Deferred Stock Units. The Company hereby grants to |
|
| December 20, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended September 27, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION (Exact |
|
| December 20, 2019 |
Exhibit 4.1 DESCRIPTION OF VAREX’S CAPITAL STOCK The following is a summary of the material terms of Varex’s capital stock contained in Varex’s amended and restated certificate of incorporation and bylaws and the in the Delaware General Corporation Law (“DGCL”). The summaries and descriptions below do not purport to be complete statements of the relevant provisions of the certificate of incorporat |
|
| November 27, 2019 |
VREX / Varex Imaging Corp NT 10-K - - NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: September 27, 2019 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q For the Transition P |
|
| November 12, 2019 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2019 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2019 SALT LAKE CITY, November 12, 2019 - Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2019. Highlights • FY19 Revenues were $781 million • FY19 Gross margin was 33% | Adjusted gross margin* was 35% • FY19 Net earnings were $0.43 per di |
|
| November 12, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organ |
|
| October 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or orga |
|
| October 1, 2019 |
Exhibit 10.1 AMENDMENT NO. 4 TO CREDIT AGREEMENT THIS AMENDMENT NO. 4 TO CREDIT AGREEMENT (this “Amendment”), dated as of September 26, 2019, is made between Varex Imaging Corporation (the “Borrower”), certain of the Borrower’s subsidiaries listed on the signature pages hereof under the heading “GUARANTORS” (each a “Guarantor”, and, collectively, the “Guarantors”), the Lenders listed on the signat |
|
| August 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| August 6, 2019 |
VAREX IMAGING ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF FISCAL YEAR 2019 Exhibit 99.1 VAREX IMAGING ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF FISCAL YEAR 2019 SALT LAKE CITY, Utah, August 6, 2019 - Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the third quarter of fiscal year 2019. Quarterly Highlights • Revenues increased 3% to $197 million • Gross margin was 31% | Adjusted gross margin* was 34% • Operating earnings margin w |
|
| August 6, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commissio |
|
| July 12, 2019 |
Material Impairments, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commission |
|
| May 28, 2019 |
Conflict Minerals Report as required by Items 1.01 and 1.02. Exhibit 1.01 Varex Imaging Corporation CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2018 This report for the year ended December 31, 2018 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). I. Overview a. Company Overview Varex Imaging Corporation (the “Company”, “Varex”, “we”, “our”, “us”) is a leading innovator, designer and manufacturer of |
|
| May 28, 2019 |
VREX / Varex Imaging Corp SD - - SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VAREX IMAGING CORPORATION (Exact name of the registrant as specified in its charter) Delaware 001-37860 81-3434516 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Add |
|
| May 8, 2019 |
AMENDMENT NO. 3 TO CREDIT AGREEMENT THIS AMENDMENT NO. 3 TO CREDIT AGREEMENT (this “Amendment”), dated as of March 21, 2019, is made between Varex Imaging Corporation (the “Borrower”), certain of the Borrower’s subsidiaries listed on the signature pages hereof under the heading “GUARANTORS” (each a “Guarantor”, and, collectively, the “Guarantors”), the Lenders listed on the signature pages hereof |
|
| May 8, 2019 |
1. SHARE PURCHASE AGREEMENT relating to Direct Conversion AB (publ) Dated 21 March, 2019 CONTENTS 1. DEFINITIONS AND INTERPRETATION 0 2. SALE AND PURCHASE 7 3. CONSIDERATION 7 4. CONDITIONS 10 5. COMPLETION 11 6. WARRANTIES OF SELLERS 13 7. PURCHASER WARANTIES 22 8. COVENANTS 22 9. INDEMNIFICATION 25 10. SPECIFIC INDEMNITY BY THE SELLERS 28 11. THIRD PARTY CLAIMS AND RECVERY 29 12. SETTLEMENT OF C |
|
| May 8, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORA |
|
| May 7, 2019 |
VAREX IMAGING ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2019 Exhibit 99.1 VAREX IMAGING ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2019 SALT LAKE CITY, Utah, May 7, 2019 - Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the second quarter of fiscal year 2019. Quarterly Highlights • Revenues were $196 million • Gross margin was 33% | Adjusted gross margin* was 34% • Operating earnings margin was 7% | Adju |
|
| May 7, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commission F |
|
| March 21, 2019 |
VAREX TO ACQUIRE LEADING LINEAR ARRAY DIGITAL DETECTOR MAKER DIRECT CONVERSION Exhibit 99.1 VAREX TO ACQUIRE LEADING LINEAR ARRAY DIGITAL DETECTOR MAKER DIRECT CONVERSION SALT LAKE CITY, Utah, March 21, 2019 - Varex Imaging Corporation (Nasdaq: VREX) announced today it has entered into an agreement to acquire at least 90% of the outstanding shares of common stock of Direct Conversion AB (publ). Stockholm-based Direct Conversion, also known by its Ajat and XCounter brands, is |
|
| March 21, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commissio |
|
| February 19, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| February 11, 2019 |
VREX / Varex Imaging Corp / VANGUARD GROUP INC Passive Investment vareximagingcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Varex Imaging Corp Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box |
|
| February 6, 2019 |
VREX / Varex Imaging Corp 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 28, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORP |
|
| February 5, 2019 |
VAREX IMAGING ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2019 Exhibit 99.1 VAREX IMAGING ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2019 SALT LAKE CITY, Utah, February 5, 2019 – Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the first quarter of fiscal year 2019. Quarterly Highlights • Revenues increased 5% to $186 million • Gross margin was 32% | Adjusted gross margin* was 36% • Operating earnings margin |
|
| February 5, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2019 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commiss |
|
| January 30, 2019 |
VREX / Varex Imaging Corp / QV Investors Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Amendment No. |
|
| January 2, 2019 |
VREX / Varex Imaging Corp DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| January 2, 2019 |
VREX / Varex Imaging Corp DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 27, 2018 |
List of Subsidiaries as of November 5, 2018 EX-21.1 3 exhibit211-10xk.htm EXHIBIT 21.1 Exhibit 21.1 VAREX IMAGING CORPORATION LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation Varex Imaging Equipment (China) Co., Ltd. China MeVis Medical Solutions AG (73.7%) Germany Varex Imagens Brasil, Ltda. Brazil Varex Imaging Holdings, Inc. Delaware, USA Varex Imaging France SARL France Varex Imaging Deutschland AG Germany Varex Imaging Italia Sr |
|
| November 27, 2018 |
Form of Grant Agreement for Deferred Stock Units under the 2017 Omnibus Stock Plan. Exhibit 10.18 VAREX IMAGING CORPORATION Grant Agreement - Deferred Stock Units (For grants made after May 25, 2018) GRANT AGREEMENT made effective as of , 20 (the “Grant Date”) between Varex Imaging Corporation, a Delaware corporation (the “Company”), and (the “Director”). 1.Grant of Deferred Stock Deferred Stock Units. The Company hereby grants to the Director Deferred Stock Units. Each Deferred |
|
| November 27, 2018 |
VREX / Varex Imaging Corp 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended September 28, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORATION (Exact |
|
| November 13, 2018 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2018 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2018 SALT LAKE CITY, Utah, November 13, 2018 — Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the fourth quarter and fiscal year 2018. Fiscal Year Highlights • Revenues increased 11% to $773 million • Gross margin was 33% | Adjusted gross margin* was 35% • Operating earnings margin |
|
| November 13, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2018 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commis |
|
| October 3, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2018 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commi |
|
| October 3, 2018 |
EX-10.1 2 varexexhibit1011032018.htm EXHIBIT 10.1 Execution Version AMENDMENT NO. 2 TO CREDIT AGREEMENT THIS AMENDMENT NO. 2 TO CREDIT AGREEMENT (this “Amendment”), dated as of September 28, 2018, is made between Varex Imaging Corporation (the “Borrower”), certain of the Borrower’s subsidiaries listed on the signature pages hereof under the heading “GUARANTORS” (each a “Guarantor”, and, collective |
|
| September 10, 2018 |
VREX / Varex Imaging Corp / VANGUARD GROUP INC Passive Investment vareximagingcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Varex Imaging Corp Title of Class of Securities: Common Stock CUSIP Number: 92214X106 Date of Event Which Requires Filing of this Statement: August 31, 2018 Check the appropriate box to |
|
| August 9, 2018 |
VREX / Varex Imaging Corp 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 VAREX IMAGING CORPORAT |
|
| August 2, 2018 |
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF FISCAL YEAR 2018 Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF FISCAL YEAR 2018 SALT LAKE CITY, Utah, August 2, 2018 - Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the third quarter of fiscal year 2018, as well as certain integration-related restructuring charges. Quarterly Highlights • Revenues increased 12% to $191 million • Gross margin was 33% | Adjus |
|
| August 2, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2018 VAREX IMAGING CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-37860 81-3434516 (Commission |
